- QLGN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
-
S-3 Filing
Qualigen Therapeutics (QLGN) S-3Shelf registration
Filed: 25 Jul 19, 9:18am
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
As independent registered public accountants, we hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated April 1, 2019 relating to the financial statements ofRitter Pharmaceuticals, Inc. as of and for the years ended December 31, 2018 and 2017 (which report includes an explanatory paragraph relating to the uncertainty of the Company’s ability to continue as a going concern), and to the reference to us under the caption “Experts,” which is contained in the Registration Statement.
/s/ Mayer Hoffman McCann P.C.
Los Angeles, California
July 24, 2019
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.